|
Sirotnak, F M; She, Yuhong; Khokhar, Nushmia Z et al. (2004) Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events. Mol Carcinog 41:150-63
|
|
Sirotnak, Francis M (2003) Studies with ZD1839 in preclinical models. Semin Oncol 30:12-20
|
|
She, Yuhong; Lee, Fei; Chen, Jing et al. (2003) The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index. Clin Cancer Res 9:3773-8
|
|
Masumoto, Naoko; Chen, Jing; Sirotnak, F M (2002) Regulation of transcription of the murine gamma-glutamyl hydrolase gene. Delineation of core promoter A and the role of LYF-1, E2F and ETS-1 in determining tumor-specific expression. Gene 291:169-76
|
|
Sirotnak, Francis M; She, Yohung; Lee, Fei et al. (2002) Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer. Clin Cancer Res 8:3870-6
|
|
Khokhar, N Z; She, Y; Rusch, V W et al. (2001) Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums. Clin Cancer Res 7:3199-205
|
|
Masumoto, N; Esaki, T; Sirotnak, F M (2001) Additional organizational features of the murine gamma-glutamyl hydrolase gene. Two remotely situated exons within the complement C3 gene locus encode an alternate 5' end and proximal ORF under the control of a bidirectional promoter. Gene 268:183-94
|
|
Sirotnak, F M; Zakowski, M F; Miller, V A et al. (2000) Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 6:4885-92
|
|
Fritz, F; Chen, J; Hayes, P et al. (2000) Molecular cloning of the murine cMOAT ATPase. Biochim Biophys Acta 1492:531-6
|
|
Sirotnak, F M; Sepp-Lorenzino, L; Kohl, N E et al. (2000) A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility. Cancer Chemother Pharmacol 46:79-83
|
Showing the most recent 10 out of 28 publications
